ARCHIVES

FDA Guidance for Public Comment at Advisory Committee Meetings

This article is from The Cancer Letter archive.

Vol. 36 No. 45 | December 10, 2010

Download PDF Visit The Full Archive

Related Articles

DCPC Board Will Consider Revised Concepts For CPRUs

September 18, 1987

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

April 22, 1994

In Brief: Tom Hall Names CMMI VP For Clinical Affairs; Rabson, Fauci Names to Institute Of Medicine

June 26, 1987

DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil.

March 9, 1990

Misconduct Finding Is ‘Rare,’ OSI official Tells NCAB

June 14, 1991